{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:19:41Z","timestamp":1789589981756,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"council\u00a0of\u00a0scientific and industrial research, india","doi-asserted-by":"publisher","award":["38 (1339)\/12\/EMR-II"],"award-info":[{"award-number":["38 (1339)\/12\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11064-021-03455-2","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T02:34:31Z","timestamp":1633833271000},"page":"422-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anticonvulsant Effect of Asparagus racemosus Willd. in a Mouse Model of Catamenial Epilepsy"],"prefix":"10.1007","volume":"47","author":[{"given":"Priyanka","family":"Pahwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-8082","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"3455_CR1","first-page":"CD013225","volume":"10","author":"MJ Maguire","year":"2019","unstructured":"Maguire MJ, Nevitt SJ (2019) Treatments for seizures in catamenial (menstrual-related) epilepsy. Cochrane Database Sys Rev 10:CD013225","journal-title":"Cochrane Database Sys Rev"},{"key":"3455_CR2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1528-1157.1997.tb01197.x","volume":"38","author":"AG Herzog","year":"1997","unstructured":"Herzog AG, Klein P, Ransil BJ (1997) Three patterns of catamenial epilepsy. Epilepsia 38:1082\u20131088","journal-title":"Epilepsia"},{"key":"3455_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2018.02.031","volume":"1703","author":"S Joshi","year":"2019","unstructured":"Joshi S, Kapur J (2019) Neurosteroid regulation of GABAA receptors: a role in catamenial epilepsy. Brain Res 1703:31\u201340","journal-title":"Brain Res"},{"key":"3455_CR4","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","volume":"78","author":"AG Herzog","year":"2012","unstructured":"Herzog AG, Fowler KM, Smithson SD, Kalayjian LA, Heck CN, Sperling MR et al (2012) Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurology 78:1959\u20131966","journal-title":"Neurology"},{"key":"3455_CR5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/acn3.50830","volume":"6","author":"S Shiono","year":"2019","unstructured":"Shiono S, Williamson J, Kapur J, Joshi S (2019) Progesterone receptor activation regulates seizure susceptibility. Ann Clin Transl Neurol 6:1302\u20131310","journal-title":"Ann Clin Transl Neurol"},{"key":"3455_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","volume":"62","author":"DS Reddy","year":"2004","unstructured":"Reddy DS (2004) Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62:99\u2013118","journal-title":"Epilepsy Res"},{"key":"3455_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.yhbeh.2012.04.016","volume":"63","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013) Neuroendocrine aspects of catamenial epilepsy. Horm Behav 63:254\u2013266","journal-title":"Horm Behav"},{"key":"3455_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1472-8206.2000.tb00411.x","volume":"14","author":"MS Benedetti","year":"2000","unstructured":"Benedetti MS (2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fundam Clin Pharmacol 14:301\u2013319","journal-title":"Fundam Clin Pharmacol"},{"key":"3455_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","volume":"19","author":"JI Isojarvi","year":"2005","unstructured":"Isojarvi JI, Tauboll E, Herzog AG (2005) Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drug 19:207\u2013223","journal-title":"CNS Drug"},{"key":"3455_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yebeh.2008.02.004","volume":"13","author":"C Guille","year":"2008","unstructured":"Guille C, Spencer S, Cavus I, Epperson CN (2008) The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment. Epilepsy Behav 13:12\u201324","journal-title":"Epilepsy Behav"},{"key":"3455_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","volume":"54","author":"MJ Brodie","year":"2013","unstructured":"Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D (2013) Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia 54:11\u201327","journal-title":"Epilepsia"},{"key":"3455_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0973-7847.99948","volume":"6","author":"P Mahendra","year":"2012","unstructured":"Mahendra P, Bisht S (2012) Ferula asafoetida: traditional uses and pharmacological activity. Pharmacogn Rev 6:141\u2013146","journal-title":"Pharmacogn Rev"},{"key":"3455_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/1947-2714.139296","volume":"6","author":"SM Bagheri","year":"2014","unstructured":"Bagheri SM, Rezvani ME, Vahidi AR, Esmaili M (2014) Anticonvulsant effect of Ferula asafoetida oleo gum resin on chemical and amygdala-kindled rats. N Am J Med Sci 6:408\u2013412","journal-title":"N Am J Med Sci"},{"key":"3455_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jep.2013.08.052","volume":"150","author":"J Sharma","year":"2013","unstructured":"Sharma J, Gairola S, Gaur RD, Painuli RM, Siddiqi TO (2013) Ethnomedicinal plants used for treating epilepsy by indigenous communities of sub-Himalayan region of Uttarakhand, India. J Ethnopharmacol 150:353\u2013370","journal-title":"J Ethnopharmacol"},{"key":"3455_CR15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S2222-1808(13)60049-3","volume":"3","author":"S Alok","year":"2013","unstructured":"Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M (2013) Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pac J Trop Dis 3:242\u2013251","journal-title":"Asian Pac J Trop Dis"},{"key":"3455_CR16","first-page":"7","volume":"30","author":"BJ Naik","year":"1988","unstructured":"Naik BJ (1988) Management of pre-eclampsia by ayurvedic drugs. J Nat Int Med Assoc 30:7\u201312","journal-title":"J Nat Int Med Assoc"},{"key":"3455_CR17","first-page":"360","volume":"44","author":"M Dwivedi","year":"1991","unstructured":"Dwivedi M, Tewari PV (1991) Dhatriyadi Yoga in obstetrics: efficacy and cost. Sachitra Ayurved 44:360\u2013362","journal-title":"Sachitra Ayurved"},{"key":"3455_CR18","first-page":"4","volume":"11","author":"PV Tewari","year":"1968","unstructured":"Tewari PV, Mata HC, Chaturvedi C (1968) Experimental study on estrogenic activity of certain indigenous drugs. J Res Ind Med Yoga Homeo 11:4\u201312","journal-title":"J Res Ind Med Yoga Homeo"},{"key":"3455_CR19","first-page":"855","volume":"2","author":"K Sharma","year":"2011","unstructured":"Sharma K, Bhatnagar M (2011) Asparagus racemosus (Shatavari): a versatile female tonic. Int J Pharma Biol Arch 2:855\u2013863","journal-title":"Int J Pharma Biol Arch"},{"key":"3455_CR20","first-page":"362","volume":"7","author":"RA Gohel","year":"2015","unstructured":"Gohel RA, Solanki BH, Gurav NI, Patel GH, Patel BH (2015) Isolation and characterization of Shatavarin IV from root of Asparagus racemosus willd. Int J Pharm Pharm Sci 7:362\u2013365","journal-title":"Int J Pharm Pharm Sci"},{"key":"3455_CR21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"NW Dunham","year":"1954","unstructured":"Dunham NW, Miya TS (1954) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 46:208\u2013209","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"key":"3455_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.compbiomed.2014.01.003","volume":"47","author":"D Singh","year":"2014","unstructured":"Singh D, Gawande DY, Singh T, Poroikov V, Goel RK (2014) Revealing pharmacodynamics of medicinal plants using in silico approach: a case study with wet lab validation. Comput Biol Med 47:1\u20136","journal-title":"Comput Biol Med"},{"key":"3455_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","volume":"784","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK (2016) Adjuvant indoleamine 2, 3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression. Eur J Pharmacol 784:111\u2013120","journal-title":"Eur J Pharmacol"},{"key":"3455_CR24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/13880209.2011.636057","volume":"50","author":"D Singh","year":"2012","unstructured":"Singh D, Singh B, Goel RK (2012) Role of saponins for the anticonvulsant effect of adventitious roots of Ficus religosa. Pharma Biol 50:816\u2013822","journal-title":"Pharma Biol"},{"key":"3455_CR25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"3455_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/bmc.1130040410","volume":"4","author":"JQ Wei","year":"1990","unstructured":"Wei JQ, Wei JL, Zhou XT, Cheng JP (1990) Isocratic reversed phase high performance liquid chromatography determination of twelve natural corticosteroids in serum with on-line ultraviolet and fluorescence detection. Biomed Chromatogr 4:161\u2013164","journal-title":"Biomed Chromatogr"},{"key":"3455_CR27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yebeh.2016.05.005","volume":"61","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK (2016) Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression. Epilepsy Behav 61:248\u2013257","journal-title":"Epilepsy Behav"},{"key":"3455_CR28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharep.2016.10.001","volume":"69","author":"T Singh","year":"2017","unstructured":"Singh T, Goel RK (2017) Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression. Pharmacol Rep 69:143\u2013149","journal-title":"Pharmacol Rep"},{"key":"3455_CR29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yebeh.2017.04.004","volume":"72","author":"N Kaur","year":"2017","unstructured":"Kaur N, Singh T, Kumar S, Goel RK (2017) Neurochemical evidence based suggested therapy for safe management of epileptogenesis. Epilepsy Behav 72:8\u201316","journal-title":"Epilepsy Behav"},{"key":"3455_CR30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","volume":"92","author":"T Singh","year":"2017","unstructured":"Singh T, Bagga N, Kaur A, Kaur N, Gawande DY, Goel RK (2017) Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. Biomed Pharmacother 92:720\u2013725","journal-title":"Biomed Pharmacother"},{"key":"3455_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2015.04.007","volume":"49","author":"T Singh","year":"2015","unstructured":"Singh T, Goel RK (2015) Neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity. Neurotoxicology 49:1\u20137","journal-title":"Neurotoxicology"},{"key":"3455_CR32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1528-1157.2001.10100.x","volume":"42","author":"DS Reddy","year":"2001","unstructured":"Reddy DS, Kim HY, Rogawski MA (2001) Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42:328\u2013336","journal-title":"Epilepsia"},{"key":"3455_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.02.017","volume":"85","author":"DS Reddy","year":"2009","unstructured":"Reddy DS (2009) The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 85:1\u201330","journal-title":"Epilepsy Res"},{"key":"3455_CR34","first-page":"303","volume":"42","author":"DS Reddy","year":"2001","unstructured":"Reddy DS, Rogawski MA (2001) Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42:303\u2013310","journal-title":"Epilepsia"},{"key":"3455_CR35","doi-asserted-by":"crossref","first-page":"106426","DOI":"10.1016\/j.yebeh.2019.07.027","volume":"101","author":"J Williamson","year":"2019","unstructured":"Williamson J, Singh T, Kapur J (2019) Neurobiology of organophosphate-induced seizures. Epilepsy Behav 101:106426","journal-title":"Epilepsy Behav"},{"key":"3455_CR36","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/epi.16715","volume":"61","author":"T Singh","year":"2020","unstructured":"Singh T, Joshi S, Williamson JM, Kapur J (2020) Neocortical injury\u2013induced status epilepticus. Epilepsia 61:2811\u20132824","journal-title":"Epilepsia"},{"key":"3455_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666210517114016","author":"S Bhatia","year":"2021","unstructured":"Bhatia S, Rawal R, Sharma P, Singh T, Singh M, Singh V (2021) Mitochondrial dysfunction in Alzheimer\u2019s disease: opportunities for drug development. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/1570159X19666210517114016","journal-title":"Curr Neuropharmacol"},{"key":"3455_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2017.12.009","volume":"111","author":"S Joshi","year":"2018","unstructured":"Joshi S, Sun H, Rajasekaran K, Williamson J, Perez-Reyes E, Kapur J (2018) A novel therapeutic approach for treatment of catamenial epilepsy. Neurobiol Dis 111:127\u2013137","journal-title":"Neurobiol Dis"},{"key":"3455_CR39","first-page":"337","volume":"153","author":"CR Craig","year":"1966","unstructured":"Craig CR (1966) Anticonvulsant activity of steroids: separability of anticonvulsant from hormonal effects. J Pharmacol Exp Ther 153:337\u2013343","journal-title":"J Pharmacol Exp Ther"},{"key":"3455_CR40","first-page":"53","volume":"1","author":"NF Salih","year":"2013","unstructured":"Salih NF, Jaafar MS (2013) Assessment of the ovulation by effects of radiation on the LH, FSH, HCG, PROG, and EST with problems in women\u2019s fertility. J Microbiol Res Rev 1:53\u201360","journal-title":"J Microbiol Res Rev"},{"key":"3455_CR41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2095-4964(15)60173-X","volume":"13","author":"SP Borse","year":"2015","unstructured":"Borse SP, Kamble BB (2015) Effects of Ayurvedic Rasayana botanicals on CYP3A4 isoenzyme system. J Integr Med 13:165\u2013172","journal-title":"J Integr Med"},{"key":"3455_CR42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.9.5.352","volume":"9","author":"J Logothetis","year":"1959","unstructured":"Logothetis J, Harner R, Morrel F, Torres F (1959) The role of estrogens in catamenial exacerbation of epilepsy. Neurology 9:352\u2013360","journal-title":"Neurology"},{"key":"3455_CR43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuroscience.2005.07.005","volume":"138","author":"J Vel\u00ed\u0161kov\u00e1","year":"2006","unstructured":"Vel\u00ed\u0161kov\u00e1 J (2006) The role of estrogens in seizures and epilepsy: the bad guys or the good guys? Neuroscience 138:837\u2013844","journal-title":"Neuroscience"},{"key":"3455_CR44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1073858406295827","volume":"13","author":"J Vel\u00ed\u0161kov\u00e1","year":"2007","unstructured":"Vel\u00ed\u0161kov\u00e1 J (2007) Estrogens and epilepsy: why are we so excited? Neuroscientist 13:77\u201388","journal-title":"Neuroscientist"},{"key":"3455_CR45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.1.02200","volume":"155","author":"SM Carlsen","year":"2006","unstructured":"Carlsen SM, Jacobsen G, Romundstad P (2006) Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol 155:365\u2013370","journal-title":"Eur J Endocrinol"},{"key":"3455_CR46","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","volume":"17","author":"T Sir-Petermann","year":"2002","unstructured":"Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE (2002) Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 17:2573\u20132579","journal-title":"Hum Reprod"},{"key":"3455_CR47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(78)90474-X","volume":"131","author":"K Klinga","year":"1978","unstructured":"Klinga K, Bek E, Runnebaum B (1978) Maternal peripheral testosterone levels during the first half of pregnancy. Am J Obstet Gynecol 131:60\u201362","journal-title":"Am J Obstet Gynecol"},{"key":"3455_CR48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/jpet.110.169854","volume":"334","author":"DS Reddy","year":"2010","unstructured":"Reddy DS, Jian K (2010) The testosterone-derived neurosteroid androstanediol is positive allosteric modulator of GABA-A receptors. J Pharmacol Exp Ther 334:1031\u20131041","journal-title":"J Pharmacol Exp Ther"},{"key":"3455_CR49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-8993(02)04065-9","volume":"964","author":"KA Kalkbrenner","year":"2003","unstructured":"Kalkbrenner KA, Standley CA (2003) Estrogen modulation of NMDA-induced seizures in ovariectomized and non-ovariectomized rats. Brain Res 964:244\u2013249","journal-title":"Brain Res"},{"key":"3455_CR50","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1152\/jn.1999.81.3.1404","volume":"81","author":"LD Pozzo-Miller","year":"1999","unstructured":"Pozzo-Miller LD, Inoue T, Murphy DD (1999) Estradiol increases spine density and NMDA-dependent calcium transients in spines of CA1 pyramidal neurons from hippocampal slices. J Neurophysiol 81:1404\u20131411","journal-title":"J Neurophysiol"},{"key":"3455_CR51","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1523\/JNEUROSCI.17-05-01848.1997","volume":"17","author":"CS Woolley","year":"1997","unstructured":"Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848\u20131859","journal-title":"J Neurosci"},{"key":"3455_CR52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5530\/rjps.2015.3.3","volume":"5","author":"RA Shastry","year":"2015","unstructured":"Shastry RA, Madagundi SD, Habbu PV, Patil BS, Joshi SD, Kulkarni VH (2015) Phytochemical investigation and antiepileptic activity of Asparagus racemosus (Wild) root extracts in rodents. RGUHS J Pharm Sci 5:97\u2013103","journal-title":"RGUHS J Pharm Sci"},{"key":"3455_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.yhbeh.2007.09.012","volume":"53","author":"RJ Handa","year":"2008","unstructured":"Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L (2008) An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5\u03b1-androstane-3\u03b2,17\u03b2-diol. Hormon Behav 53:741\u2013752","journal-title":"Hormon Behav"},{"key":"3455_CR54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2826.2009.01840.x","volume":"21","author":"RJ Handa","year":"2009","unstructured":"Handa RJ, Weiser MJ, Zuloaga D (2009) A role for the androgen metabolite, 5\u03b1-androstane-3\u03b2, 17\u03b2-Diol, in modulating oestrogen receptor \u03b2-Mediated regulation of hormonal stress reactivity. J Neuroendocrinol 21:351\u2013358","journal-title":"J Neuroendocrinol"},{"key":"3455_CR55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(93)90497-B","volume":"629","author":"MA Kling","year":"1993","unstructured":"Kling MA, Smith MA, Glowa JR, Pluznik D, Demas J, DeBellis MD et al (1993) Facilitation of cocaine kindling by glucocorticoids in rats. Brain Res 629:163\u2013166","journal-title":"Brain Res"},{"key":"3455_CR56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0028-3908(94)90147-3","volume":"33","author":"AJ Roberts","year":"1994","unstructured":"Roberts AJ, Keith LD (1994) Sensitivity of the circadian rhythm of kainic acid-induced convulsion susceptibility to manipulations of corticosterone levels and mineralocorticoid receptor binding. Neuropharmacology 33:1087\u20131093","journal-title":"Neuropharmacology"},{"key":"3455_CR57","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1460-9568.1999.00495.x","volume":"11","author":"H Karst","year":"1999","unstructured":"Karst H, De Kloet ER, Jo\u00ebls M (1999) Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur J Neuroscience 11:889\u2013898","journal-title":"Eur J Neuroscience"},{"key":"3455_CR58","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yebeh.2017.10.025","volume":"78","author":"A Hooper","year":"2018","unstructured":"Hooper A, Paracha R, Maguire J (2018) Seizure-induced activation of the HPA axis increases seizure frequency and comorbid depression-like behaviors. Epilepsy Behav 78:124\u2013133","journal-title":"Epilepsy Behav"},{"key":"3455_CR59","doi-asserted-by":"crossref","first-page":"135618","DOI":"10.1016\/j.neulet.2020.135618","volume":"764","author":"T Basu","year":"2021","unstructured":"Basu T, Maguire J, Salpekar JA (2021) Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Neurosci Lett 764:135618","journal-title":"Neurosci Lett"},{"key":"3455_CR60","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/10520295.2013.769630","volume":"88","author":"B Baykara","year":"2013","unstructured":"Baykara B, Aksu I, Buyuk E, Kiray M, Sisman AR, Baykara B et al (2013) Progesterone treatment decreases traumatic brain injury induced anxiety and is correlated with increased serum IGF-1 levels; prefrontal cortex, amygdala, hippocampus neuron density; and reduced serum corticosterone levels in immature rats. Biotech Histochem 88:250\u2013257","journal-title":"Biotech Histochem"},{"key":"3455_CR61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.physbeh.2010.02.002","volume":"99","author":"S Andrade","year":"2010","unstructured":"Andrade S, Silveira SL, Arbo BD, Batista BA, Gomez R, Barros HM, Ribeiro MF (2010) Sex-dependent antidepressant effects of lower doses of progesterone in rats. Physiol Behav 99:687\u2013690","journal-title":"Physiol Behav"},{"key":"3455_CR62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbr.2012.06.034","volume":"234","author":"Y Li","year":"2012","unstructured":"Li Y, Pehrson AL, Budac DP, S\u00e1nchez C, Gulinello M (2012) A rodent model of premenstrual dysphoria: progesterone withdrawal induces depression-like behavior that is differentially sensitive to classes of antidepressants. Behav Brain Res 234:238\u2013247","journal-title":"Behav Brain Res"},{"key":"3455_CR63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbr.2013.09.002","volume":"256","author":"Y Li","year":"2013","unstructured":"Li Y, Raaby KF, S\u00e1nchez C, Gulinello M (2013) Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats. Behav Brain Res 256:520\u2013528","journal-title":"Behav Brain Res"},{"key":"3455_CR64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pbb.2008.07.010","volume":"91","author":"GK Singh","year":"2009","unstructured":"Singh GK, Garabadu D, Muruganandam AV, Joshi VK, Krishnamurthy S (2009) Antidepressant activity of Asparagus Racemosus in rodent models. Pharmacol Biochem Behav 91:283\u2013290","journal-title":"Pharmacol Biochem Behav"},{"key":"3455_CR65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","volume":"22","author":"MS Starr","year":"1996","unstructured":"Starr MS (1996) The role of dopamine in epilepsy. Synapse 22:159\u2013194","journal-title":"Synapse"},{"key":"3455_CR66","first-page":"149","volume":"350","author":"QS Yan","year":"1994","unstructured":"Yan QS, Jobe PC, Cheong JH, Ko KH, Dailey JW (1994) Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch Pharmacol 350:149\u2013152","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3455_CR67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yebeh.2016.10.007","volume":"66","author":"T Singh","year":"2017","unstructured":"Singh T, Goel RK (2017) Managing epilepsy-associated depression: serotonin enhancers or serotonin producers? Epilepsy Behav 66:93\u201399","journal-title":"Epilepsy Behav"},{"key":"3455_CR68","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1007\/s11064-017-2325-6","volume":"42","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK (2017) Ferulic acid supplementation for management of depression in epilepsy. Neurochem Res 42:2940\u20132948","journal-title":"Neurochem Res"},{"key":"3455_CR69","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s11064-021-03257-6","volume":"46","author":"S Thapliyal","year":"2021","unstructured":"Thapliyal S, Singh T, Handu S, Bisht M, Kumari P, Arya P, Srivastava P, Gandham R (2021) A review on potential footprints of ferulic acid for treatment of neurological disorders. Neurochem Res 46:1043\u20131057","journal-title":"Neurochem Res"},{"issue":"6","key":"3455_CR70","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11064-021-03274-5","volume":"46","author":"T Singh","year":"2021","unstructured":"Singh T, Goel RK (2021) Epilepsy associated depression: an update on current scenario, suggested mechanisms, and opportunities. Neurochem Res 46(6):1305\u20131321","journal-title":"Neurochem Res"},{"key":"3455_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00823-3","author":"T Singh","year":"2021","unstructured":"Singh T, Mishra A, Goel RK (2021) PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-021-00823-3","journal-title":"Metab Brain Dis"},{"key":"3455_CR72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuint.2016.12.023","volume":"104","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK (2017) Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int 104:27\u201333","journal-title":"Neurochem Int"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03455-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03455-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03455-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:40:47Z","timestamp":1644388847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03455-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03455-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}